Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: Results from the phase 3 PARADIG MS study

Douglas L. Arnold, Brenda Banwell, Amit Bar-Or, Angelo Ghezzi, Benjamin M. Greenberg, Emmanuelle Waubant, Gavin Giovannoni, Jerry S. Wolinsky, Jutta Gärtner, Kevin Rostásy, Lauren Krupp, Marc Tardieu, Wolfgang Brück, Tracy E. Stites, Gregory L. Pearce, Dieter A. Häring, Martin Merschhemke, Tanuja Chitnis